13 results
8-K
EX-2.1
TPST
Tempest Therapeutics Inc
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
425
EX-2.1
TPST
Tempest Therapeutics Inc
29 Mar 21
Business combination disclosure
7:27am
8-K
EX-2.1
TPST
Tempest Therapeutics Inc
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
EX-2.1
TPST
Tempest Therapeutics Inc
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-2.2
m7ogrd1c4ko3gwu6x9zw
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.3
bx33vxg1yixupj69
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.1
g7bqyxtdvd0d g1n
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.4
c38k3vy7bntm
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
msuy nqrh9vva7
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.3
9vs 6b0q24pbz46u
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.2
s0o8o
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.4
tu5xyl9x
9 Aug 18
Business combination disclosure
5:17pm
- Prev
- 1
- Next